treatment protocol to follow with drugs and dosage in detail for seizure in dogs

Reading File
Finding Sources
Searching PubMed

canine epilepsy seizure treatment protocol

Searching the Web

canine seizure treatment protocol drugs dosage 2024 IVETF guidelines

Reading Web Page

https://abvp.com/wp-content/uploads/2024/06/2024-07-July-Can…

Finding Sources
Reading Web Page

https://www.merckvetmanual.com/nervous-system/epilepsy-in-sm…

Searching PubMed

canine epilepsy antiepileptic drug treatment levetiracetam phenobarbital

Here is the detailed seizure treatment protocol for dogs, based on the 2024 ACVIM Consensus Statement, Merck Veterinary Manual, and current veterinary practice guidelines.

Canine Seizure Treatment Protocol

Step 1 - Definitions & Indications to Treat

TermDefinition
Single seizureOne isolated seizure event
Cluster seizures (CS)2+ seizures within 24 hours
Status epilepticus (SE)Single seizure lasting ≥5 minutes OR 3+ seizures within 24 hours without full recovery between events
When to start long-term maintenance therapy (IVETF recommendation):
  • 2+ seizures within 6 months
  • Any episode of SE or cluster seizures
  • Severe/prolonged postictal period
  • Increasing seizure frequency, duration, or severity
  • Structural brain lesion or history of brain injury

Step 2 - Emergency Treatment (Active Seizure / SE / Cluster Seizures)

First-Line: Benzodiazepines

DrugRouteDoseNotes
Midazolam (IN)Intranasal0.2 mg/kgOut-of-hospital or in-hospital; preferred for home/field use; onset 2-5 min
DiazepamIV0.5 mg/kg slow pushIn-hospital; may repeat x2 at 5-min intervals
DiazepamRectal1.0 mg/kgIf no IV access
MidazolamIM0.2 mg/kgAlternative if no IV; faster absorption than diazepam IM
  • Can repeat benzodiazepine up to 3 doses total
  • If seizures continue after 3 doses, escalate to second-line

Second-Line: Loading Dose of Maintenance ASM

If seizures persist after benzodiazepines, administer a loading dose:
DrugRouteDoseNotes
PhenobarbitalIV or IM15-20 mg/kg total, divided into 4 mg/kg aliquots every 20-30 minDivide doses to avoid cardiorespiratory depression
LevetiracetamIV (over 5-15 min)30-60 mg/kgVery safe; minimal hepatic metabolism; good choice alongside phenobarbital
Both can be given together if needed. If the dog is already on phenobarbital maintenance, levetiracetam loading is preferred as second-line.

Third-Line: Anesthetic/Refractory SE

For SE not responding to first- and second-line treatment:
DrugDoseNotes
Propofol1-4 mg/kg IV bolus, then 0.1-0.6 mg/kg/min CRITitrate to effect; requires ventilatory support monitoring
Ketamine1-5 mg/kg IV bolus, then CRIACVIM Recommendation A for dogs (2024)
Dexmedetomidine0.5-2 mcg/kg/min CRIUsed if SE persists after ketamine (ACVIM Recommendation B)
Diazepam/Propofol CRIVariable - titrate to seizure cessationMonitored anesthesia required
Pentobarbital2-15 mg/kg IV slowlyLast resort; causes coma; full anesthetic monitoring required
For refractory SE: A four-step approach is used - ketamine first, then dexmedetomidine, then escalation to barbiturate anesthesia.

Step 3 - Maintenance (Long-Term Antiseizure Medications)

First-Line Maintenance Drugs

1. Phenobarbital (Highest Recommendation)

  • Dose: 2-5 mg/kg PO q12h (starting at 2-3 mg/kg)
  • Adjust based on serum concentrations, seizure control, and adverse effects
  • Target trough serum concentration: 15-35 mcg/mL
  • Time to steady state: ~2-3 weeks
  • Monitoring: Serum levels at 2-3 weeks after starting or dose change, then every 6 months; liver enzymes (ALT, ALP) and bile acids every 6-12 months
  • Side effects: Polyuria/polydipsia/polyphagia (PU/PD/PP), sedation, hepatotoxicity (long-term), facial pruritus

2. Imepitoin (High Recommendation - Europe; not available in all countries)

  • Dose: 10-30 mg/kg PO q12h (starting at 10 mg/kg)
  • Partial benzodiazepine receptor agonist - lower abuse/tolerance risk
  • First-line for newly diagnosed idiopathic epilepsy in dogs
  • Fewer adverse effects than phenobarbital; no hepatotoxicity

Second-Line / Add-On Drugs

3. Potassium Bromide (KBr) (Moderate Recommendation)

  • Dose (add-on): 15-20 mg/kg/day PO (divided to reduce GI upset)
  • Dose (monotherapy): 40 mg/kg/day PO
  • Sodium bromide: decrease dose by ~15% compared to KBr
  • Target serum concentration: 1-2.5 mg/mL (with phenobarbital); 1-3 mg/mL (monotherapy)
  • Time to steady state: ~3-4 months without loading
  • Check levels at 8-12 weeks, then every 6-12 months
  • Note: NOT for use in cats (causes irreversible pulmonary disease)

4. Levetiracetam (Low Recommendation for monotherapy; widely used as add-on)

  • Immediate-release: 20-60 mg/kg PO q8h (starting at 20 mg/kg)
  • Extended-release: 30 mg/kg PO q12h
  • IV emergency dose: 30-60 mg/kg over 5-15 min
  • Increase by 20 mg/kg increments if needed
  • Minimal adverse effects - considered very safe
  • Clearance increased when combined with phenobarbital or KBr - dose adjustments likely needed

5. Zonisamide (Low Recommendation; useful as add-on)

  • Dose: 5-10 mg/kg PO q12h (dogs)
  • Hepatic metabolism; potential hepatotoxicity - monitor liver enzymes
  • Useful in dogs intolerant of phenobarbital

6. Gabapentin (Adjunct)

  • Dose: 5-10 mg/kg PO q8-12h
  • Primarily adjunctive; limited evidence as sole ASM

Pulse Therapy for Cluster Seizure Prevention

Oral clorazepate (benzodiazepine) can be used as rescue/pulse therapy in dogs with known cluster seizure tendencies:
  • Dose: 0.5-1 mg/kg PO q8h, started at onset of first seizure in a cluster, continued for 24-48h
  • Reduces risk of additional seizures within the cluster period

Step 4 - Supportive Care (All Seizure Presentations)

  • Secure IV access immediately
  • Check blood glucose - treat hypoglycemia if present (dextrose 0.25-0.5 mL/kg of 50% dextrose IV diluted 1:4)
  • Monitor body temperature - active cooling if >40.5°C (hyperthermia secondary to seizure activity)
  • Monitor respiration and oxygen saturation
  • Baseline labs: CBC, chemistry, electrolytes, urinalysis; check for metabolic/toxic causes
  • Keep in visible monitored kennel for at least 24h after cluster seizures or SE
  • Treat underlying cause if identified (e.g., hypoglycemia, toxin, hepatic encephalopathy)

Summary Flow Chart

ACTIVE SEIZURE
     |
     v
1st LINE: Benzodiazepine
  - IN Midazolam 0.2 mg/kg  (preferred out-of-hospital)
  - IV Diazepam 0.5 mg/kg   (preferred in-hospital)
  - Repeat up to 3x
     |
  No response
     v
2nd LINE: Load ASM
  - IV Phenobarbital 15-20 mg/kg (divided)
  - IV Levetiracetam 30-60 mg/kg (if already on pheno)
     |
  No response (Refractory SE)
     v
3rd LINE: Anesthesia
  - Ketamine CRI
  - Propofol CRI
  - Dexmedetomidine CRI
  - Pentobarbital (last resort)
     |
     v
MAINTENANCE ASM
  - Phenobarbital 2-5 mg/kg PO q12h (1st line)
  + KBr or Levetiracetam if needed

Key Monitoring Parameters

DrugMonitoringFrequency
PhenobarbitalSerum trough level (15-35 mcg/mL), liver enzymes, bile acids2-3 weeks post-start, then q6 months
KBrSerum bromide level (1-3 mg/mL), chest radiograph8-12 weeks, then q6-12 months
LevetiracetamClinical assessment; serum levels optionalAs needed
ZonisamideLiver enzymesq6 months

Important: Primidone is no longer recommended due to significantly higher hepatotoxicity risk compared to phenobarbital. All dosing should be individualized based on patient response, serum drug concentrations, and adverse effects. Consult a veterinary neurologist for refractory cases.
This is a shared conversation. Sign in to Orris to start your own chat.